A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: I Ganly, D Kirn, G Eckhardt, G I Rodriguez, D S Soutar, R Otto, A G Robertson, O Park, M L Gulley, C Heise, D D Von Hoff, S B Kaye, S G Eckhardt
Institution: Cancer Research UK Scotland Institute
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2132002141